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INTRODUCTION 
0'Shaughnessy1 first suggested the treatment of patients with intravenous 
fluids in the early 1800's. Subsequently, Dr. s Latta2 and Weatheri113 and others 
treated patients by administering solutions of selected salts intravenously . Un-
til the 1920's, hospitals depended exclusively upon solutions prepared in their 
own laboratories. Techniques allowing large volume commercial production 
were not developed until the late 1920's and in 1929 Dr. Don Baxter (Don Baxter, 
Inc.) began providi.ng commercial intravenous fluids in the Los Angeles, Cali-
fornia, area and nationwide in late 1931. 4 
A greater awareness is now recognized for the complexities of intravenous 
fluid production, not just from the standpoint of sterility but for pyrogenicity, 
formulation and administration. Basically, the formulae and methods of admin-
istration today are little different from the earlier hospital produced fluids. 
The delivery system of the intravenous fluid has traditionally been the 
rigid glass bottle with some device to allow air venting. The venting allows 
equalization of air pressure by permitting ambient air to enter the bottle . This 
has been accomplished in one of two ways. First, a ball-check valve (many 
early systems used a "butter-fly" device) t hat permitted the ambient ai r to 
enter the bottl e and pass through the fluid . Usually the devices provided some 
type of gross filtration of the air, but by no means was sterilization achieved. 
Second, a vent tube running the length of the bottle and directing ambient air 
into the bottle over the surface of the fluid. It should be noted that in each 
case the non-stel"ile ambient air comes into intimate contact with the intl"a-
venous fluid. The delivery sjrstem as a unit represents an open pathway into 
the patients' veins and the non-sterile ambient air is a potential vehicle for in-
troducing Ol"ganisms into this pathway. 
There was no alte-rnative available if the physician wanted to administer 
intravenous fluids to his patient. Any system used relied upon non-stel"ile am-
bient air in order to function; liowevel" a new intravenous fluid administration 
system is now available in the United States. 'I'l"avenol Laboratories has now 
marketed intravenous fluids in a flexible plastic bag (ViaflexR) that does not 
rely on entry of ambient air to function. The plastic bag simply collapses to 
allow the fluid to vacate the container. 
The official literature disseminated by 'I'l"avenol Laboratol"ies refers to 
the ViaflexR system as 11an innovation in parenteral packaging. n Advantages 
sited for this system are: reduced weight, reduced bulk, freedom from break-
age as a result of cal"eless handling or exposure to freezing. However, a patient 
would benefit only indirectly fl"om these advantages. A mol"e impol"tant con-
sidel"ation fo ... the patient is safety. Does this 11innovation in parentel"al pack-
aging" subject the patient to less risk of septicemia resulting from a contami-
nated intravenous fluid administration system? 
Microbial contamination of an intravenous fluid may occur in many ways, 
but among these, three are foremost. 
l. During manufacture of the fluid and components 
2. In preparation of the delivery system prior to administration 
3. During actual administration of the fluid to the patient 
By utilizing recognized good manufacturing practices plus adequate con-
trols, the manufacturer is able to virtually eliminate the first source of con-
tamination. During the course of this study, background data was collected to 
verify this observation. 
Contamination occurring during assembly of the system and that encoun-
tered during actual administration becomes more difficult to eliminate. The 
propensity for contamination during assembly of the system is determined by 
the design of the system and the technique utilized by the individual preparing 
the system. A poorly engineered delivery system or one with serious design 
deficiencies would require meticulous technique from the individual. Such a 
system would be constantly challenged and subject the patient to an undue risk. 
Contamination arising during the administration of the fluids would be deter-
mined by the basic design of the system and its dependence on environmental 
factors. 
The intent of this study was to methodically explore microbial contamina-
tion of a traditional glass bottle system and the newer flexible plastic bag 
system simultaneously. Utilizing nurses in a patient care area and pharma-
cists in a central additive service configuration each system was subjected to 
conditions approximating actual situations. The frequency of microbial growth 
in either system was used to serve as a comparison between the two systems. 
REVIEW 0 F THE LITERATURE 
For many years authors have been expressing fears of airborne microbial 
contamination. Wells and Wells5 accurately stated the problem although, in a 
somewhat flowery ,manner; "In the dissemination of plant life, the atmosphere 
is nature 1s prime sower of the seed and thus vitally affects all living things. " 
The suggestion that common air supplies be rendered free of microbial contami-
nation, while impractical on the scale outlined by Wells and Wells6, is precisely 
what is being attempted today on a limited basis in laminar air flow hoods and 
in clean rooms. Elaborate filtration devices are not the only means of ach iev-
ing an atmosphere with fewer bacteria. By the use of sterile dust-free surgical 
gowns, Duguid and Wallace7 showed that one source of bacterial contamination, 
i.e. dust-borne bacteria, could be drastically reduced. The study conducted by 
Cole and BernardS indicated that careful housekeeping techniques could be ex-
pected to reduce the contamination level. Other workers have found that very 
basic matters such as the number of personnel in a given area and the extent of 
physical activity also played key roles in the levels of air-borne microbial con-
tamination encountered. 9 Ford, Petersen, and MitchelllO came to the same 
conclusions and suggested the control of traffic in the operating rooms to reduce 
the level of air-borne microbial contamination. 
The role of technique and the person preparing the intravenous fluids for 
administration in contributing to microbial contamination of the intravenous 
fluids was shown by the work of Love.ll This study indicated that imprope,. 
assembly of the intt·avenous fluid administ,.ation system was an important factor 
in the rate of microbial contamination resulting. 
In examining a series of actual in use intravenous fluids, Deeb and Nat-
sios12 attempted to provide a value for the frequency of microbial contamination. 
Their study showed that the patient receiving intravenous fluids must be consi-
dered a being at risk. ' Hermanl3 endeavored to provide the pl"acticing pharma-
cist with an appreciation of the role he may play in contributing to microbial 
contamination by pointing out that healthy hospital workers may carry recognized 
pathogens. This point was corrOborated by the work of Williamsl4 showing that 
transient carriage of Staphylococcus aureus by healthy individuals could be harmful 
to patients. 
The prominent epidemic of septicemias arising from the use of contami-
nated intravenous fluids , first documented by Duma, Warner and Daltonl5 is 
an example of contamination occu,.ring at the point of manufacture. The extent 
and possible underlying source of the contamination was subsequently noted by 
the Center for Disease Controt.l6 Reports are still appearing in the literature 
documenting specific casesl7 and various methodologies employed in other out-
breaks studied.l8 
The report of Rupp and Fornil9 documents a previously unregognized means 
of contamination of an intravenous fluid, that of actual entry of an insect into 
the container via the vent tube. The potential of this means of contamination 
was suggested in an editorial from England20 pointing out that these insects may 
be carrie"t"S of pathogenic microorganisms . This break in the integrity of the 
system was directly related to the basic design of the administration container. 
Henry and Harrison21 warned of the potential for contamination resulting 
from the improper use of volume control sets in administering intravenous 
fluids; a warning also voiced by Duma, Warner, and Dalton. 15 
The literature abounds with articles describing septicemias resulting from 
in-dwelling intravenous catheters. 22- 33 Other reports appear in which intra-
venous fluid therapy is indicted as the most frequent source of infection34 or 
evidence strongly suggests the fluid as the source of contamination. 35 
The gentle flow of air into the vacating fluid container does not alone repre-
sent the means of introducing the microbial contaminants into the fluid . Michaels 
and Ruebner36 detected bacterial growth in intravenous fluids during administra-
tion and concluded the contamination occurred "either while the bottles were 
being changed or by contaminated air sucked into one of the bottles through the 
air-replacement tube." It was subsequently shown experimentally by Perceva137 
that the inrush of ambient air upon opening the fluid bottle with a partial vacuum 
could be the vehicle for introducing organisms into the intravenous fluid. Con-
current environmental air sampling was used by Perceval to serve as a compari-
son of the risk factor. Perceval found that the degree of environmental contamina-
tion did affect the rate of fluid contamination. 0 1Hare, Shapiro and Creeden38 
concluded that air microbial contamination has to reach a certain level to become 
clinically significant, although that level was not defined. 
In the study conducted by Arnold and Hepler, 39 the contamination rate of 
fluids opened in various areas of their hospital ranged from zero to nearly 10%. 
The overall contamination rate was approximately 5% and in their opinion raised 
serious queStions regarding the safety of intravenous fluids being opened in a 
contaminated environment. A subsequent study by Hansen40 at the same institu-
tion concluded that an open or air-dependent system was more likely to become 
contaminated through the entry of non-sterile air when the partial vacuum was 
released . Hansen further suggests these air-dependent systems be opened only 
in a l aminar air flow hood to minimize the contamination potential. 
Clearly, the literature shows that a great many people have been concerned 
for a number of years with the potential for infections in the hospital environment. 
This concern has included the administration of intravenous fluids and any source 
that may be contributary, L e. manufacture, assembly of the unit and administra-
tion. 
DESCRIPTION 0 F THE STUDY 
The study in question was designed to examine a new intravenous fluid 
delivery system from the standpoint of microbial contamination. To serve 
as the base-line, a traditional delivery system was subjected to identical pro-
cedures concurrently with the new system. 
The major differences between the two systems being studied was the fluid 
containe-r. The traditional container consisted of the glas s bottle with a vent 
tube running the length of the bottle. The new system was a flexible plastic 
bag that did not require the entry of ambient air for evacuation. 
In recognition of the alternatives that exist with regard to intravenous fluid 
preparation, both nurses and pha,.macists were utilized in the study. Obviously, 
vastly different conditions existed in the areas used by the study personnel for 
actual preparation of the fluids. The pharmacists used a certified laminar air 
flow hood and the recognized procedures of the Medical College of Virginia 
Hospital Pharmacy of a lint-free gown, surgical mask and cap. The procedure 
also included a scrub using a sterile 3o/c hexachlorophene sponge and cleansing 
of the hood and all materials placed inside the hood with a solution of 70% iso-
propyl alcohol. The nurses prepared their fluids in a medication room, unal -
tered from the normal setting with regard to traffic, housekeeping, ventilation, 
and distractions. 
The particular nurses were carefully chosen to find ones having had no prior 
experience with the new system and no prior instruction in the recommended pro-
cedures. Likewise the pharmacists had no instructions in handling the new system 
but they were somewhat familiar with the flexible plastic bag. 
Each nurse and pharmacist then proceeded to prepare one liter of an intra-
venous fluid containing one additive and attached an administration set and a final 
filter distal to the administration set. At the nursing unit (the same medication 
room) the nurses then attached a needle and proceeded to run the intravenous fluid 
into a sterile evacuated collection bottle. (Figure 1) 
When the fluids had almost emptied, they were clamped with the device pro-
vided by the manufacturer and allowed to stand at room temperature for approxi-
mately 24 hours undisturbed. 
The fluids were next collected by study personnel and delivered to the labora-
tory for sampling. After collecting the necessary samples, the materials were 
delivered to the laboratory for incubation and speciation. 
To provide a positive concurrent control on both sampling technique and micro-
biology detection methods, small quantities of Escherichia co li (ATCC 11229) were 
added to one bottle and one bag of fluids of each one-day run. The addition of the 
microorganism was performed by the nurse or pharmacist preparing the fluids 
and the unit contaminated was unknown to both the persons performing the sam-
pling and those in the microbiology laboratory. 
Specifically the study was to proceed in the following fashion: 
Phase One: collection of laboratory background data of individual 
components, by the study personnel. 
lO 
Phase Two: preparation of the intravenous fluid systems by nurses 
on a patient care unit. 
Phase Three: preparation of the intravenous fluid systems in a laminar 
air flow hood by pharmacists, using the prevailing stan-
dards of the department. 
ll 
MATERIALS AND METHODS 
MATERIALS 
The intravenous fluids and administration sets utilized were manufactured 
by Baxter-Travenol Laboratories , Inc. (Morton Grove, Til. 60053). The in-
travenous fluid selected was 5% Dextrose in Lactated Ringer 1s packaged in one 
liter quantities in the traditional glass bottle (catalog number 2A2074) and the 
ViaflexR flexible plastic bag (catalog number 2B2074) . The administration 
set was the PlexitronR R-42 set (catalog number 2C0005). The additive se-
lected to be included in each unit was 0. 9% Sodium Chloride without a preser-
vative, packaged in 30 ml single dose vials, manufactured by Baxter-Travenol 
Labor atories, Inc. (catalog number 2D4543). All supp1ies were purchased on 
the open market through normal distribution channels. 
Millipore Corporation (BediDrd, Mass.) manufactured the Swinnex-25R 
0. 45p in-line final filter (catalog number SXHA0250S) used throughout the study. 
Empty Vacuum Plasma collection bottles were used to collect the filtered intra-
venous fluids and were manufactured by Baxter- Travenol Laboratories, Inc. 
(catalog number 2A8504). 
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METHODS 
All bacteriological manipulations were performed in a l aminar air flow 
hood (Abbott Clean Air Center, Bench Model BK No.l024) by the same two in-
dividuals, a phys ician and a pharmacist. The l aminar air flow hood itself 
was certified during the course of the study (November 3, 1971, and June 29, 
1972) by Contamination Control Labs (located in Livonia, Michigan). Prior 
to use the laminar air flow hood was prepared by allowing to run for at least 
one hour and swabbing the inside surfaces (top, sides and work area) with 
70% isopropyl a lcohol. Before beginning any sampling procedures, blood 
agar settling plates were placed on either side of the work area and fastened 
to the sides (approximately 8- 12 inches from the outside edge) at a 450 angle 
to interdict the flow of filtered air. The settling plates we-re left in place 
until the sampling procedures had been completed; the last activity to be removal 
of the blood agar settling plates, secure the top in pl ace, and deliver the ex-
posed plates to the bacteriology laboratories for incubation and identification. 
Incubation was for seven days at 37oc , being checked daily for growth. 
Phase One: Background Data Collection 
Background data was collected to prove the sterility of all individual com-
{X>nents and to provide a check on the technique of those performing the s ampling. 
In this phase of the study, fifty (50) one liter glass bottl es of 5% Dextrose in 
Lactated Ringer's, fifty (50) one liter flexible plastic bags of 5% Dextrose in 
Lactated Ringer 's, forty (40) int ravenous infusion sets , and fifty-four (54) final 
in-line filters were sampled. Actual sampling was performed in the following 
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mannet' for the glass bottles. First , the metal ring and metal disc weT"e removed 
outside of the laminar air flow hood. Next the surface of the latex covering was 
dried with sterile gauze and the surface then flamed. The intravenous fluid bot-
tle was then placed in the laminar air flow hood in a horizontal configuration with 
the vent tube in the lower position. The vacuum was next released by inserting 
a sterilized air filter through the hole provided for the infusion set. (The ste-
rilized air filter was prepared by removing the plunger of a five cc syringe and 
placing a plug of cotton in the barT"el and attaching a one and one-half inch twenty 
guage needle ; the entire unit was wrapped and sterilized.) Ten ml of the intraven-
ous fluid was removed with a sy,.inge through the vent tube of the bottle. The 
opening of a bottle containing eighty ml of fluid thioglycollate tre dia was next 
flamed and the ten ml of intravenous fluid then aseptically added. The opening 
of the bottle was again fl amed and the top replaced. The contents of the bottle 
were then incubated at 37°C for seven days and any resulting growth speciated. 
The flexible plastic bags were next sampled using a similar procedure with 
a few exceptions. After removing the intravenous fluid in the plastic bag from 
the outer plastic wrap , an Oschner clamp was used to support the medication port 
and the latex surface flamed. Since no procedures were required to equalize 
p't'essure as seen with the traditional glass bottle, the lO ml sample of the fluid was 
next withdrawn. Addition of the sample to the bottle containing fluid thioglycollate 
media was performed in an identical manner to that described for the glass bottle. 
In order to subject the intravenous infusion sets to the same sterility and 
procedural checks performed on other components of the study, fluid thioglycollate 
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media was flushed through each set. A rubber-stoppered container of fluid 
thioglycollate media was flamed, swabbed with a sterile alcohol swab, and 
20 ml of media withdrawn by a needle and syringe in the laminar air flow hood. 
After passing the media through the length of the intravenous infusion set, it 
was collected in a sterile screwcapped test tube. The opening of the screw-
capped test tube was flamed before and after addition of the media. 
The final-in-line filters were removed from the manufacturers package 
and a sterile intravenous infusion set and 20 guage 11/2" needle attached. The 
complete unit, filter, needle and set, was then allowed to stand for 24 hours 
in the same medication room to be used by the nurses in the study in their 
assembly of bottles and bags of fluids. At the end of this incubation period, 
the filter, needle, and infusion set units were transported to the hospital phar-
macy for sampling. The unit was dis-assembled in the laminar air flow hood 
and the filter case opened, the filter membrane and gasket removed using 
flamed forceps and placed top down on a blood agar plate for one to two hours. 
In the microbiology laboratory, the filter membrane and gasket were removed 
and placed in a test tube containing fluid thioglycollate media. Both media were 
then incubated as other media used in the study and any resulting growth noted. 
Phase 'l\vo: Preparation by Nurses on a Patient Care Unit 
Fifty-five (55) glass bottles and fifty-five (55) flexible plastic bags were 
sampled in addition to the control solutions by registered nurses accustomed 
to handling intravenous fluids. In this phase of the study, all supplies required 
by the nurses to prepare the intravenous fluids were delivered to the unit and 
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the nurses left alone to prepare them without intimate supervision. While the 
study personnel were available (by either paging or telephone) for any problems 
that may be encountered, they were not physically on the unit during the manipu-
lations. The nurses were allowed to read any literature that accompanied the 
fluid but no additional instructions were forthcoming. The intravenous fluids 
were to be prepared as for any patient except (l) the additive to be used was 
0. 9% Sodium Chloride (2) a final in-line filter was to be used (3) instead of 
inserting the needle into the patient's vein , the fluid was allowed to run into 
the empty vacuum bottles supplied. 
The additives were prepared in the following manner. The nurse, using 
a 20 ml syringe, withdrew 20 ml of the 0. 9% Sodium Chloride without a preser-
vative from the 30 ml single dose vial. Ten ml of the additive was injected into 
the intravenous fluid container and the remaining 10 ml in the syringe left for the 
study personnel. The following day when the completed fluids were retrieved, 
the 10 ml of additive in the syringe was transported to the pharmacy with all 
other supplies, and in a laminar air flow hood injected into a bottle containing 
80 ml of fluid thioglycollate media and incubated at 37°C for seven days. This 
procedure provided a method of checking each additive for sterility and therefore, 
subjected the system to another check of its integrity. 
After the nurse completed the assembly of the system, she regulated the 
flow rate to allow one liter to be emptied in approximately two hours. Before 
the entire liter was emptied, the nurse was requested to stop the flow leaving 
50-100 ml of fluid remaining in the container . The entire unit was then allowed 
to stand until the following day (18-24 hours) undisturbed , on the nursing unit 
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Next, the study personnel picked up all of the units and transported them intact 
to the hospital pharmacy for sampling. In transportation the units were carried 
along the same pathway a patient would follow if movement were required. 
In the laminar air flow hood the samples were collected as follows. The 
fi rst 10 ml of the remaining intravenous fluid to pass through the needle s till at-
tached to the final fil ter and set was collected in a bottle containing 80 ml of fluid 
thioglycollate media. The top of the screw-capped bottl e was flamed before and 
after the sample was added. The remainder of the intravenous fluid was allowed 
to run through the intact set and filter , the last 5 to 10 ml being Collected in an 
empty sterile screw-capped test tube. The test tube top was flamed before and after 
addition of the sample . Next the final in-line filter was removed fr om the set-up. 
The unit was disassembled and using flamed forceps , the gasket and the filte r 
membrane aseptically removed in the laminar a ir flow hood to a blood agar plate; 
top s ide of each facing the media sur face. 
The lO ml sample of the additive in the syringe was added to the media in a 
manner previously described. 
The samples were then transported to the microbiology laboratory and the 
same technician performed the following actions. The two bottles containing 
the fluid thioglycollate media (the firs t 10 ml o f flu id drawn from the set-up after 
overnight on the ward and the 10 ml additive control ) were placed in the incubator 
at 37°C. From the test tube containing the last fluid to pass through the set and 
filte r, a 0 . 5 ml sample was removed and stre aked on a blood agar plate. Next 
another 0 . 5 ml sample was r emoved and streaked on an EMB plate (eosin methylene 
blue). Finally, 1 ml was removed to a sterile petri dish and a pour plate pr epared 
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using Soybean Casein Digest Agar. All three of these samples were also incu-
bated at 37oc. 
The blood aga.,. plates containing the gasket and filte,. memb.-ane we .... e opened 
and each .,.emoved to a separate test tube containing fluid thioglycollate media. 
The th.,.ee samples were likewise incubated at 37oc. Each day the incubat-
ing samples were checked and any resulting growth speciated. Incubation and 
daily checking of the samples con tinued fo r seven days. 
Phase ThT'ee: Prepa ... ation of the Intravenous Fluids in a Laminar Ai-r Flow Hood 
by Pharmacists 
In this phase of the s tudy, a phar·macist accustomed to handling intr·avenous 
fluids p,.epal'ed the set-up as would be expected in a cenb·al additive service. 
The pharmacists p.,.epa,.ed a total of fifty-five (55) glass bottles and fifty-fou.,. 
(54) flexible plastic bags containing the int.,.avenous fluids. The same supplies 
we.,.e p.,.ovided to the pha-rmacist as noted in phase two. Each pha-rmacist fol-
lowed the usual pha-rmacy p-rocedu.,.e fo.,. p.,.epa.,.ing int-ravenous fluids which in-
eluded a hand sc-rub us ing a ste-rile 3% hexachlo.,.ophene sc.,.ub sponge (catalog 
numbe.,. 3000, Pha.,.maseal Labo.,.ato.,.ies) , and wearing a lint-f.,.ee cap and gown , 
and a su.,.gical mask. The fluids we ... e p ... epa.,.ed in a simila-r manne.,. to phase two, 
with .,.ega..-d to the additive utilized. The 10 ml .,.emaining in the sy.,.inge again 
se-rved as the cont ... ol fo.,. the additive. The pha.,.macist also inse.,.ted the fluid 
administ-ration set and attached the final in-line fil te.,.. Since the fluids p.,.epa..-ed 
in the glass bottle had an open vent tube, some means of plugging the vent tube 
fo.,. transit had to be devised. A ste ... ile plastic device was aseptically inse..-ted 
into the vent tube by the pha..-macist to fulfill this pu.,.pose. The assembled unit 
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was transported to the nursing station by pharmacy personnel and left for her to 
11administer". The nurse then attached the appropriate needle, where indicated 
withdrew the sterile vent tube plug devic~ and ran the fluids into the empty col-
lection bottl e provided. Regulation of the flow rate, retrieval by study personnel, 
sampling procedur es and microbiology methods were identical to phase two. The 
same room and conditions were also used for the nurses 1 portion of the exper iment. 
In both phase two and phase three, the nurse or pharmacist selected one bot-
tle and one plastic bag and deliberately contaminated that unit with a solution con-
taining Escherichia coli. The identity of the contaminated unit was unknown to the 
personnel per forming the sampling and microbiological techniques. 
19 
RESULTS 
Phase One: Background Data (Table l) 
The fifty (50) one liter plastic bags of 5% Dextrose in Lactated Ringer 1s 
did not exhibit any evidence of contamination by the study methodology employed. 
However, a like number of one liter glass bottles of the same fluid resulted in 
one bottle yielding a positive culture for a Penicillium species . Th is repre-
sents a rate of contamination of 2%. No pos itive cultures resulted from forty 
(40) intravenous infusion sets sampled. The fifty-four (54) final in-line filters 
sampled produced two positive cultures for a rate of 3. 7%. The organisms 
isolated from the filters were a Staphylococcus epidermidis and a Flavobacterium 
species. 
Blood agar settling plates placed in the laminar air flow hood during all of 
these sampling procedures yielded a Bacillus species, a Staphylococcus epider-
~. a Mycelium sterilia, a Penicillium species and an Aspergillus species. 
Phase Two: Preparation By Nurses on a Patient Care Unit (Tables 2 &. 3) 
Three general duty registered nurses prepared a total of fifty-five (55) liters 
of intravenous fluids in the glass bottle and fifty-five (55) liters in the plastic bag. 
Of the fifty-five (55) glass bottles, four bottles were positive; a rate of 7 . 1%. 
The organisms isolated were a Bacillus species, a Streptococcus species and 
a Staphylococcus epidermidis. The same number of fluids in the plastic bag 
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produced six pos itive cultures or a rate of 10 . 9%. Here the organisms were 
a Bacillus species , a Micrococcus spec ies, and a Staphylococcus epidermidis. 
Settling plates of blood agar in the laminar air flow hood concurrent with t he 
sampling procedures revealed a Staphylococcus epidermidis , a Bac illus spec ies , 
and a Micrococcus species. Blood agar settling plates placed in the same room 
during nurse preparation yielded an Aspergillus species, a Staphylococcus au reus, 
a Staphylococcus epidermidis, a Micrococcus species, a Streptococcus s pecies, 
and a Bacillus species. With the fluids in glass bottles, one nurse (C) accounted 
for all four of the contaminated fluids detected . However, when utilizing the 
fluids in plastic bags , this same nurse had no fluids contaminated although the 
other two nurses (A and B ) each contr ibuted three contaminated fluids to the 
total of s ix detected . 
Phase Three: Pharmacist Preparation in a Laminar Air Flow Hood (Tables 4 & 5) 
The two pharmacists prepared fifty-five (55) liters of fluids in glass bottles 
and fifty -four (54) liters in plastic bags. Three glass bottles were found pos it ive 
for a contamination rate of 5. 4%. The organisms isolated were a Staphylococcus 
epidermidis, a Micrococcus species , and a Bacillus species. The fifty-four (54) 
liters in the plastic bag produced three positive cultures; a contamination rate of 
5. 5%. With the plastic bags the organisms were an Escherichia coli , a Bacillus 
spec ies and a Staphylococcus aureus. 
The blood agar settling plates from the l aminar air flow hood during sampling 
yielded a~ species, a Mic rococcus species, and a Staphylococcus ep ider-
~ Pharmacist B contributed two contaminated fluids to pharmacist A's 
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one contaminated fluid fo .... both the glass bottle and plastic bag se-..ies but in each 
instance, B p.,.epa ... ed a ~eate .... numbe.- of fluids than did A. 
Subsequent discussions with the pha.,.macist involved -..evealed that the plastic 
bag that became contaminated with the Esche.,.ichia coli was p,.epa.,.ed immediately 
afte.,. pu .... posely contaminating a glass bottle with the cont.,.ol o.,.ganism, an Esche-
.... ichia coli. The mic..-obiology labo ... ato-..y subjected both cultu,..es to fu ... the.,. testing 
and fom1d each to give the same fe..-mentation patte-..ns with those suga ... .,.eactions 
known to be va.,.iable in the genus Esche ... ichia; p-..esumpti ve evidence that the o ... -
ganism emanated f.,.om same sou-rce as the control o ... ganism. 
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STATISTICAL ANALYSIS 
The .,..esults of the study we.,..e subjected to statistical analysis by Fishers 1 
Exact Test and the Chi SquaT'e Test. 
The data indicate the contamination .,.ate fo,. nurse p,.epa,.ation of the 
plastic bags was significantly ~eater than the backwound when examined at 
the 5% level. (Table 6). 
When small sample sizes a-re utilized, such as this study, .,.ates of less 
than 50% occur,.ence will tend to be undeT'estimated mo,.e often than ove,.esti-
mated. The example stated by Schor41 provides a graphic demonstration of 
this tendency. Assuming a prevalence rate of 5% fo,.. an occu,. ... ence, and using 
ve-ry small sample sizes of five, 774 samples out of every 1000 will yield a O% 
p-revalence T"ate (an underestimate) and only 226 out of 1000 on the ave,.age 
will yield ,.ates ove,.. 5% (an overestimate). TheT'efol"e, a lal"gel" sample size 
would be l"equil"ed to ovel"COme this tendency. 
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DISCUSSION 
As stated by Dudrick42 "The intravenous route is generally recognized as 
the most definite and practical means of systemic administration of medication 
and rapid or massive infusion of electrolytes and fluids. 11 This statement accu-
rately justifies the need for a means of administering intravenous fluids in a 
practical and efficient manner. However, the patient should be afforded the 
benefits of this valuable therapeutic tool without being subjected to any unnec-
cessary risk. 
While the incident reiX'lrted by Rupp and Forn_il9 i s probably an isolated 
occurrence, the undesirable nature of an air-dependent administration system 
cannot be denied. By utilizing a non-air dependent system, e. g. ViaflexR, 
the potential indicated by Perceva1,37 Arnold and Hepler, 39 and Hansen40 
could be eliminated, although the clinical significance of the open airway has 
not been demonstrated. More concern must be shown for the mode of admin-
istering intravenous fluids, but at the same time, any new approach must 
undergo careful scrutiny. 
In conducting a study of this nature, selection of the personnel is a vital 
factor. The operation of a centralized additive service, the configuration se-
lected for the pharmacists participation in this shtdy, requ ires that the personnel 
be familiar with the rudiments of aseptic technique and possess the ability to 
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perfOTm these tasks without contaminating the system being utilized. It would 
be anticipated that personnel in this a,.ea would be somewhat familiar with the 
tasks to be performed, although likely of diffe.,..ent degy-ees of pl"Qficiency. 
Therefore, the pharmacists selected fo.,. the study were experienced in an addi-
tive operation, exhibited a high level of pT'oficiency and an above average awa ... e-
ness for contamination potential. In rega'"d to the selection of nu"'sing personnel 
for the study, it was felt that to utilize only those nurses thoroughly schooled and 
familiar with the new syftem would be somewhat tmrealistic. The intewtty of the 
delivery system must be examined in the light of the inevitable staff turnover of 
of nursing and the necessary time lag in t-raining new personnel. To include only 
nu~ses proficient and expe~ienced in a new delive~y system would tend to p-..oduce 
spu~ious ~esults and imply a lowe~ contamination ~ate than would be encounte~ed 
in the no~mal nurse population. In choosing nurses unfamilia~ with the non-ai~ 
dependent delivery system, the system was essentially being challenged to de-
te~mine its limitations in the face ofimp~ope~ technique. However, to moT'e 
fully answer this question of improper technique would require training of these 
same nurses, allowing them to become proficient and then ~epeating this phase of 
the study. 
The phaT'macists did pe.,..form one task that is not considered to be routine 
in many centralized additive p.,..ograms . Each intravenous fluid p.,..epared by the 
pharmacists had the administration set attached in the lamina,. ai~ flow hood, 
along with the final in-line filte,.. As a -..esult, when the nnits a.,..,..ived at the 
nu.,.sing station the nurse had only to attach the needle to the filte~ and inse,.t 
into the vacuum containeT'. 
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In viewing the data one must appreciate the conditions that are identical 
and those dissimilar. The nurse assembly of the unit, including needle attach-
ment to pha,.macy p.,.epa ... ed fluids, was affected in an a.,.ea no,.mally utilized 
fo.,. this pu,.pose. The medication ..-oom had its normal t>·affic, no attempt being 
made to alte ... the envi.-onment. On the othe"' hand, pharmacist assembly used an 
a ... ea free f...am excessive t>-affic, in a ..-oom with the air w-ossly filtel"ed and the 
actual prepa-ration in a laminar air flow hood. One condition standard to fluids 
prepared in both a-reas was the wa,.d environment in which the fluids were r\Ul 
and allowed to incubate ove"'night. He.,..e again, no attempt was made to alter 
the conditions from those no,.mally encounte,.ed. 
The value of positive concu.,.,.ent controls cannot be undel'est:i.mated. It 
would be most difficult to assess the findings of a study of microbial contamina-
tion in the absence of data to define the sensitivity of the procedures. Obviously, 
one must be able to retrieve organisms added as controls with a de~ee of relia-
bility and sensitivity that produces a valid finding. For this pu,.pose one unit of 
each system was innoculated with a knov.rn concentration of Esche.,.ichia coli fo,. 
each se.,.ies ... un. Although the rnic.,.oo ... ganisms were added on a blind basis, the 
contaminated unit being known only to the nu,.se o.,. pha.,.macist p.,.epa.,.ing the 
fluid, the cont--01 solution was identified in each instance . 
The concent.,.ation of the control solution of Escherichia coli .,.anged f,.om 
113 Colony Fo.,.ming Units pe,. 10 ml to 230 Colony. Fo,.ming Units pe ... lo ml with 
an ave ... age concent.,.ation of 171 Colony Fo,.ming units per 10 ml. No attempt was 
made to quantitate the Escherichia coli recove ... ed f,.om the control solutions. 
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Based on the concentrations of the contT-ol solutions added to the one lite"" conta:il-
ers, the lowe-.. limits of detection would appea ... to be less than one colony forming 
unit peT' millilite,.. Howeve,., the ideal detection capability should be one colony 
forming unit in the entire container, since a solution with one micl'Oo.,.ganism is 
contaminated. 
Chance obse,.vation .,.evealed that mic ... oo,.ganisms f.-om the control fluids 
were not found in the filtrate, i. e . the fluid collected afte,.. passing thT"ough the 
final filter , except in one incident when the filte"" memb ... ane was found to be 
.-uptured when opened. This finding would appea-.. to a~ee with othe.,.s43 indi-
cating that the final filte ... effectively •·emoves most bacteda from the fluid be-
ing administeT"ed. 
When one begins to examine the mic,.oo,.ganisms encormte ... ed in any wo.,.k 
of this natu.,.e, the immediate tendency of the neophyte is to classify the o-..gan-
is ms by pathogenicity, i.e. pathogenic o,. non-pathogenic. In ,.eality, howeve,. , 
the potential fo-.. pathogenicity must include the o,.ganisms that constitute the 
body flo-..a and may subsequently cause an oppo-..ttmistic infection. 44 Dalton and 
Allison45 showed that Staphylococcus epide,.midis , usually conside,.ed non-patho-
genic, was the causative agent in a significant pe,.centage of bacte,.emias in thei,.. 
hospital. Although usually conside-..ed to be contaminants, the p-..esence of mic,.o-
o .. ganisms such as Staphylococcus epide,.midis must be viewed with conce,.n 
since bacte ... ial endoca.-ditis ... esulting f-rom this agent cannot be conside.-ed a 
... a•·ity · 45 Some wo ... ke ... s have suggested that these facultatively pathogenic o ... -
gantsms may be an inte ... mediate g""'up between the ... eally non-pathogenic st--ains 
and documented pathogenic st--ains of staphylococci. 46 In any event the p ... esence 
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of mic,.oo ... ganisms in intravenous fluids must be conside,.ed potentially ha ... mful 
... egardless of the origin of contamination . 
The mic.,..oorganisms encounte..-ed in this study appea,.ed to be frOm touch 
contamination. The significance of ai.,.-bo .... ne contamination was not shown. 
Those mic.-oo.,.ganisms found in the collection of backg.-ound data could easily 
be attributed to technique, but never-the-less , at a level acceptable to the 
s tudy pe,.sonnel and pe ... mitting advancement to the subsequent phases. 
It is interesting to note that nead y one- fouT'th of the glass bottles pT'e-
pa,.ed by one nurse we""e contaminated, the othe,. two nurses having no bottles 
contaminated (Table 2). However , thi s same nu,..se , when utili zing the plastic 
bag had none contaminated while the othe ... two nul"ses had appl"oximately one-
sixth of each of thei"s contaminated (Table 3). The explanation fo" thi s finding 
was not appa"ent. 
When the pha"macists P"epa"ed the fluids in a Htmina" ai" flow hood, 
the findings we"e the same fo" both glass bottles and plastic bags, no diffe"ence 
in eithe" the ,.ate of contamination o" the individual pl'"epa"ing the fluid (Tables 
4 & 5) . The occu""ence of the one plastic bag with Esche"ichia coli contami -
nation was the cause of conside"able conce"n . While it appea"ed the Esche"ichia 
~was the same s train as used fo" control pul'"poses, this contamination in the 
hands o f a most capable pha"macist shows that the l amina" ai" flow hood alone 
does not assu"e ste"ility of admixtu"es. Meticulous ca"e must be exe"cised 
by the pe..-sonnel at all times even in the l amina" ai" flow hood. The standa"d 
p-rocedul'"es e mployed by the pha"macists in this s tudy, i.e. a disposable lint-fl'"ee 
&own with elastici zed wdst bands, a sul'"gical mask and cap and the SCl'"ub procedu"e 
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with sterile 3% hexachloT'Ophene should be considered the minimum acceptable 
standard. Cleansing of all products placed in the hood with 70% isopropyl al-
cohol reduces pa.,.ticulate matter and keeps the micT'Obial contamination to a 
minimum, both of vital concern to the practicing pha"'macist. 
The blood aga.,. settling plates placed in the laminar air flow hood 
during each sampling procedure further indicates that the environment inside 
the hood is fa.,. from steT'ile (Tables 1-5). DuT"ing the sampling procedures, 
study personnel wo-re surgical masks and sterile gloves while wo"'king in the 
laminar ail" flow hood and did not WOT'k betw-een the filte,.. and the blood agar 
settling plates. 
The individual preparing admixtures must not undertake this task 
with a cavalieT' attitude on the false assumption the laminar air flow hood will 
cover up his shortcomings. 
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CONCLUSIONS & RECOMMENDATiONS 
The following points can be concluded from this study: 
1. Using per sonnel with no training in the proper use of the flexible plastic 
bag, no s ignificant difference in the contamination rate could be seen 
when compared to the traditional glass bottle. 
2. A non- air- dependent intravenous fluid administration system should prove 
safer for the patient in that non-sterile ambient air cbes not enter the con-
tainer and come into intimate contact with the fluid . 
3. Based on the organisms detected, the data show that touch contamination 
is the major source of contamination in the intravenous fluid delivery 
systems tested. 
4. A central intravenous fluid additive service c an be expected to ,.educe the 
level o f contamination encountered in the fluids if the proper technique i s 
employed. 
5. A laminar air flow hood alone is not suffic ient to insure sterile intravenous 
fluids . Hospital pharmacists should utilize the laminar air flow hood cou-
pled with a greate"t" awareness of the technique required to provide a sterile 
product. 
6. The laminar air flow hood does have limitations and should not be challenged 
by the operator , his l ack. of proper attire, and i mproper technique . 
7 · Ail·borne contamination was not shown to be a majo,. facto,. in overall con-
tamination of intravenous fluids. 
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The intravenous fluid delivery system should be designed to require a 
minimum of manipulations to administer to the patient since touch contami-
nation appears to play a major role in contamination. 
The introduction of the non- air-dependent intravenous fluid delivery sys-
tem is the first s tep in closing the entire intravenous administration system 
to entry of microorganisms. The airborne contamination, although of undocu-
mented clinical significance, has been eliminated by the flexible pl astic bag. 
The next area that should be attacked by first the pharmacist and then industry 
is the problem of touch contamination. The individual pharmacist in the hos-
pital may take action by attaching the administration set in the environment of 
the laminar air flow hood, thereby • preventing ex)Xlsure of the system to an 
uncontrolled situation. Next industry may take the initiative by providing an 
intravenous fluid administration system of proven sterility by manufacture of 
the container and administration set as an integral unit, eliminating manipula-
tions at the patient bedside, the medication room, or even the laminar air flow 
l10od. Admittedly, this approach would be less flexible from the stand)Xlint of 
multiple administration sets, than is now seen, but the decision must be made. 
Is contamination of intravenous fluids the price to pay for the flexibility of 
numerous different administration sets? 
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Component 
Cultured 
Fluid in Flexible 
Plastic Bags 
Fluid in Gl ass I 
Bottles 
Infusion Sets 
I Final In-line 
Filters 
Blood Agar Settling 
Plates in Lamin3.r 
Air Flow Hood 
TABLE I 
Number of Positive Cultures and Microorganisms Isolated 
from Individual Components - Bickground Data 
Number of 
Components 
50 
50 
40 
54 
16 
Number of 
Positive Cultures 
1 (2%) 
2 (3. 7%) 
4 (25%) 
Species of 
Organism Isolated 
None Isolated 
Penicillium species 
None Isolated 
Staphylococcus epider-
midis 
Flavobacterium species 
~ 
~ 
Bacillus species, 
Penicillium s pecies, 
Aspergillus species, 
Mycelium sterilia, 
Staphylococcus epidermidiE 
Nurse 
A 
B 
c 
Controls 
Total Less 
Controls 
Blood Agar 
Settling Plates 
in Laminar Air 
Flow Hood 
TABLE 2 
Number of Positive Cultures and Microorganisms Isolated 
from Units Assembled by Nurses 
on a Patient Care Unit - Glass Bottles 
Number of 
Units Prepared 
19 
18 
18 
55 
18 
Number of 
Positive Cultures 
4 (22%) 
9 ~OO%) 
4 (7.1%) 
3 ~6. 7%) 
Species of 
Organism Isolated 
None Isolated 
None Isolated 
Staphylococcus epidermidis, 
Bacillus ~()t::t.: t t::~ 
Streptococcus species , 
Escherichia coli 
Staphylococcus epidermidis, 
Bacillus species, 
~occus species 
Staphylococcus epidermidis, 
Micrococcus species, 
Bacillus species 
w 
m 
Nurse 
A I 
B 
c 
Controls 
Total Less 
Controls 
Blood Agar I 
Settling Plates 
in Laminar Air 
Flow Hood 
TABLE 3 
Number of Positive Cultures and Microorganis ms Isolated 
from Units Assembled by Nurses 
on a Patient Care Unit - Plastic Bags 
Number of Number of 
Units Prepared Positive Cultures 
19 3 (15. 8%) 
18 3 ~6 . 7%) 
18 0 
9 9 ~00%) 
55 s n o.9%) 
18 I 3 (16.W!;) 
Species of 
Organism Isolated 
Bacillus species, 
staj?hYiOcoccus epidermidis , 
Micrococcus species 
~species , 
Micrococcus species 
None Isolated 
Escherichia coli 
Bacillus species, 
~coccus epidermidis, 
Micrococcus species 
Staphylococcus epidermidis , 
Bacillus species , 
~ccus species 
"' ~ 
Pliarmacist I 
A I B\1 
Control s 
Total Less 
Controls 
Blood Agar 
Settling Plates 
in Laminar Air 
Flow Hood 
TABLE 4 
Number of Positive Cultures and Microorganisms 
Isolated from Units Assembled by Pharmacis ts 
in a Laminar Air Flow Hood - Glass Bottles 
Number of Number of 
Units Prepared Pos itive Cultures 
23 1 (4. 3%) 
32 2 (6 . 2%) 
10 10 (100%) 
55 3 (5 . 4%) 
20 3 (15%) 
Species of 
Or ganism Isolated 
Staphylococcus epide rmidis , 
Micrococcus species , 
Bacillus species 
Es cherichia coli 
Staphylococcus epiderm idis , 
Micr ococcus species , 
Bacillus species 
Staphylococcus epidermidis , 
Bacillus species, 
MiCroCoccus species 
~ 
'" 
Pharmacist I 
'A 
I ~ ' 
Controls 
Total Less 
Controls 
Blood Agar 
Settling Plates 
in Laminar Air 
Flow Hood 
TABLE 5 
Number of Positive Cultures and Microorganisms 
Isolated from Units Assembled by Pharmacists 
in a Laminar Air Flow Hood - Plastic Bags 
Number of Number of 
Units Prepared Positive Cultures 
24 1 (4.2%) 
30 2 (6. 7%) 
10 10 (100%) 
54 3 (5. 5%) 
20 3 ~5%) 
Species of 
Organism Isolated 
Escherichia coli 
Staphylococcus aureus, 
Bacillus species 
Escherichia coli 
Escherichia coli, 
Bacillus species, 
Staphylococcus aureus 
Staphylococcus epidermidis, 
Bacillus species, 
~ccus species 
"' 
"' 
TABLE 6 
Statistical Analysis 
Confidence Limit at 95% Interval (P=0.05) 
Background Pharmacists 
Plastic Bags 0. 08 0 . 02-0.17 
Glass Bottles O.Ol-0.13 0.01-0.17 
Nurses 
0.06-0 . 27 
0.025-0.19 
.. 
0 
41 
FIGURE I 
Configuration of Complete Units as Tes ted 
A. Site for ins ertion of administration set 
B. Drip chamber of admin is tration set 
C. Rolle r clamp supplied by manufacturer 
D. Final in - line fil ter 
E. Vacuum collect ion bottle 
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